Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi

[1]  J. Beeson.  Faculty Opinions recommendation of Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. , 2014 .

[2]  T. Horii,et al.  Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response. , 2013, Blood.

[3]  T. Horii,et al.  Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana , 2012, International journal of cancer.

[4]  K. Straif,et al.  Carcinogenicity of malaria and of some polyomaviruses. , 2012, The Lancet. Oncology.

[5]  Pardis C Sabeti,et al.  Human cerebral malaria and Plasmodium falciparum genotypes in Malawi , 2012, Malaria Journal.

[6]  M. Wahlgren,et al.  TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation. , 2011, Acta tropica.

[7]  R. Biggar,et al.  African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. , 2011, The American journal of tropical medicine and hygiene.

[8]  Wendy Prudhomme O'Meara,et al.  Changes in the burden of malaria in sub-Saharan Africa. , 2010, The Lancet. Infectious diseases.

[9]  Jaap M Middeldorp,et al.  Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study , 2010, Infectious Agents and Cancer.

[10]  Pierre Baldi,et al.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray , 2010, Proceedings of the National Academy of Sciences.

[11]  H. Jaffe,et al.  Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings , 2010, Infectious Agents and Cancer.

[12]  M. Wahlgren,et al.  Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. , 2009, Seminars in cancer biology.

[13]  Pardis C Sabeti,et al.  A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking , 2008 .

[14]  W. Quint,et al.  Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: A case-control study in Uganda , 2008, Infectious Agents and Cancer.

[15]  C. Boshoff,et al.  Associations between Burkitt Lymphoma among Children in Malawi and Infection with HIV, EBV and Malaria: Results from a Case-Control Study , 2008, PloS one.

[16]  V. Beral,et al.  Antibodies against malaria and Epstein‐Barr virus in childhood Burkitt lymphoma: A case‐control study in Uganda , 2008, International journal of cancer.

[17]  M. Wilson,et al.  Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk , 2007, Tropical medicine & international health : TM & IH.

[18]  M. Wahlgren,et al.  Increased B Cell Survival and Preferential Activation of the Memory Compartment by a Malaria Polyclonal B Cell Activator1 , 2006, The Journal of Immunology.

[19]  Umberto D'Alessandro,et al.  Variation in malaria transmission intensity in seven sites throughout Uganda. , 2006, The American journal of tropical medicine and hygiene.

[20]  P. Doyle,et al.  Results from a Case-Control Study of Risk Factors for Congenital Heart Defects in Saudi Arabian Infants , 2006 .

[21]  A. Moormann,et al.  Endemic Burkitt's lymphoma: a polymicrobial disease? , 2005, Nature Reviews Microbiology.

[22]  M. Wahlgren,et al.  Identification of a Polyclonal B-Cell Activator in Plasmodium falciparum , 2004, Infection and Immunity.

[23]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[24]  K. Schulz,et al.  Descriptive studies: what they can and cannot do , 2002, The Lancet.

[25]  O. Branch,et al.  Plasmodium falciparum Genotypes, Low Complexity of Infection, and Resistance to Subsequent Malaria in Participants in the Asembo Bay Cohort Project , 2001, Infection and Immunity.

[26]  M. D. Wilson,et al.  Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season , 2001, Parasitology.

[27]  Svensson,et al.  Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. , 1999, The Journal of infectious diseases.

[28]  Joseph D. Smith,et al.  Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes , 1995, Cell.

[29]  H. Whittle,et al.  Circulating Epstein-Barr virus-carrying B cells in acute malaria , 1991, The Lancet.

[30]  R. Biggar,et al.  Malaria in urban and rural areas of southern Ghana: a survey of parasitaemia, antibodies, and antimalarial practices. , 1984, Bulletin of the World Health Organization.

[31]  N. Day,et al.  Seasonal variation in onset of Burkitt's lymphoma in the West Nile District of Uganda. , 1974, Lancet.

[32]  P. Feorino,et al.  Malaria antibody levels in patients with Burkitt's lymphoma. , 1974, The American journal of tropical medicine and hygiene.

[33]  A. Bluming,et al.  Cell kinetics of African cases of Burkitt lymphoma. A preliminary report. , 1972, European journal of cancer.

[34]  A. Bluming,et al.  Burkitt's lymphoma and malaria. , 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene.